The year in cardiovascular medicine 2020: heart failure and cardiomyopathies.
作者信息
Bueno Héctor, Moura Brenda, Lancellotti Patrizio, Bauersachs Johann
机构信息
Multidisciplinary Translational Cardiovascular Research Group. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro, 3, Madrid 28029, Spain.
Cardiology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación Sanitaria Hospital, 12 de Octubre (imas12), Madrid, Spain.
出版信息
Eur Heart J. 2021 Feb 11;42(6):657-670. doi: 10.1093/eurheartj/ehaa1061.
PMID:33388764
Abstract
摘要
相似文献
1
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies.2020年心血管医学领域：心力衰竭与心肌病
Eur Heart J. 2021 Feb 11;42(6):657-670. doi: 10.1093/eurheartj/ehaa1061.
2
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.2021 年心血管医学年度回顾：心力衰竭和心肌病。
Eur Heart J. 2022 Feb 3;43(5):367-376. doi: 10.1093/eurheartj/ehab887.
3
Neprilysin Inhibitors in Cardiovascular Disease.心血管疾病中的中性肽链内切酶抑制剂
Curr Cardiol Rep. 2017 Feb;19(2):16. doi: 10.1007/s11886-017-0827-0.
4
First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice.实践中的一流复合血管紧张素受体-中性内肽酶抑制剂（ARNI）
Clin Pharmacol Ther. 2017 Aug;102(2):265-268. doi: 10.1002/cpt.736. Epub 2017 Jun 21.
5
First-in-class angiotensin receptor neprilysin inhibitor in heart failure.心力衰竭的首创血管紧张素受体脑啡肽酶抑制剂。
Clin Pharmacol Ther. 2013 Oct;94(4):445-8. doi: 10.1038/clpt.2013.146. Epub 2013 Jul 19.
6
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.血管紧张素受体-脑啡肽酶抑制剂与标准治疗相比用于射血分数降低的心力衰竭患者的估计 5 年治疗需要人数，以预防心血管死亡或心力衰竭住院：来自 PARADIGM-HF 试验的数据分析。
JAMA Cardiol. 2018 Dec 1;3(12):1226-1231. doi: 10.1001/jamacardio.2018.3957.
7
Pharmacology of heart failure: From basic science to novel therapies.心力衰竭的药理学：从基础科学到新疗法。
Pharmacol Ther. 2016 Oct;166:136-49. doi: 10.1016/j.pharmthera.2016.07.004. Epub 2016 Jul 25.
8
Angiotensin receptor neprilysin inhibitors in older patients with heart failure.血管紧张素受体脑啡肽酶抑制剂用于老年心力衰竭患者
BMJ Evid Based Med. 2019 Feb;24(1):5-7. doi: 10.1136/bmjebm-2018-110949. Epub 2018 Jul 10.
9
Angiotensin-Neprilysin Inhibition as a Paradigm for All?血管紧张素-中性肽链内切酶抑制作用能否成为通用范例？
Curr Cardiol Rep. 2016 Nov;18(11):115. doi: 10.1007/s11886-016-0784-z.
10
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.血管紧张素受体拮抗剂与中性内肽酶抑制剂联合使用
Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622.
引用本文的文献
1
The association between serum uric acid to high-density lipoprotein cholesterol ratio and heart failure: a cross‑sectional study.血清尿酸与高密度脂蛋白胆固醇比值和心力衰竭之间的关联：一项横断面研究。
BMC Cardiovasc Disord. 2025 Aug 29;25(1):641. doi: 10.1186/s12872-025-05121-9.
2
Role of circadian rhythms in heart failure: insights from myocardial energy metabolism.昼夜节律在心力衰竭中的作用：来自心肌能量代谢的见解
J Transl Med. 2025 Jul 10;23(1):770. doi: 10.1186/s12967-025-06828-1.
3
Mechanisms and Prevention Strategies of Macrophage Involvement in the Progression From Hypertension to Heart Failure.巨噬细胞参与高血压向心力衰竭进展的机制及预防策略
Int J Hypertens. 2025 Jun 20;2025:2618127. doi: 10.1155/ijhy/2618127. eCollection 2025.
4
Area-weighted unipolar voltage to predict heart failure outcomes in patients with ischaemic cardiomyopathy and ventricular tachycardia.面积加权单极电压预测缺血性心肌病伴室性心动过速患者心力衰竭结局。
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euad346.
5
The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats.曲美他嗪联合氯沙坦治疗可减轻 Ren-2 转基因大鼠心脏缝隙连接蛋白 43 和细胞外基质的压力和容量超负荷改变。
Sci Rep. 2023 Nov 27;13(1):20923. doi: 10.1038/s41598-023-48259-2.
6
COVID-19 and the Use of Angiotensin II Receptor Blockers in Older Chronic Hypertensive Patients: Systematic Review and Meta-Analysis.COVID-19 与老年慢性高血压患者中血管紧张素 II 受体阻滞剂的使用：系统评价和荟萃分析。
Medicina (Kaunas). 2023 Jun 26;59(7):1200. doi: 10.3390/medicina59071200.
7
Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.铜稳态与铜诱导的细胞死亡在心血管疾病发病机制中的作用及治疗策略。
Cell Death Dis. 2023 Feb 11;14(2):105. doi: 10.1038/s41419-023-05639-w.
8
Association between short-term exposure to ambient air pollution and heart failure: An updated systematic review and meta-analysis of more than 7 million participants.短期暴露于大气污染与心力衰竭之间的关联：超过 700 万参与者的更新系统评价和荟萃分析。
Front Public Health. 2023 Jan 23;10:948765. doi: 10.3389/fpubh.2022.948765. eCollection 2022.
9
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation.囊性纤维化跨膜转导调节因子校正可减轻心力衰竭引起的肺部炎症。
Front Immunol. 2022 Jul 28;13:928300. doi: 10.3389/fimmu.2022.928300. eCollection 2022.
10
Designer Functional Nanomedicine for Myocardial Repair by Regulating the Inflammatory Microenvironment.通过调节炎症微环境设计用于心肌修复的功能性纳米药物
Pharmaceutics. 2022 Mar 31;14(4):758. doi: 10.3390/pharmaceutics14040758.
Zotero 插件